NCT07499362 2026-04-16
Study of Pimicotinib in Japanese Participants With Tenosynovial Giant Cell Tumor (TGCT) (J-MANEUVER)
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Phase 2 Recruiting
Clinical Trials
6 trialsNCT04703322 2026-03-04
A Study of Pexidartinib in Tenosynovial Giant Cell Tumor in Japan
Daiichi Sankyo
Phase 2 Active not recruiting
NCT05349643 2024-07-05
A Study to Evaluate Safety and Efficacy of AMB-05X Injections in Subjects With TGCT
AmMax Bio, Inc.
Phase 2 Completed
NCT04731675 2024-06-27
An Open-Label Study of Intra-articular AMB-05X Injections in Subjects With Tenosynovial Giant Cell Tumor of the Knee
AmMax Bio, Inc.
Phase 2 Completed
NCT04938180 2024-05-24
A Phase 2 Study of Intravenous AMB-05X in Tenosynovial Giant Cell Tumor Patients
AmMax Bio, Inc.
Phase 2 Terminated
NCT01643850 2021-01-05
MCS110 in Patients With Pigmented Villonodular Synovitis (PVNS)
Novartis
Phase 2 Completed